Innovative Directions in Health, Minneapolis, MN, USA.
Gynecol Endocrinol. 2010 Feb;26(2):81-5. doi: 10.3109/09513590903184134.
Menopausal women are deficient in estrogen, progesterone, and frequently in testosterone and DHEA. Hormone replacement therapy (HRT) in the United States has generally consisted of one or two agents, typically equine estrogen and medroxyprogesterone, with increased risk of heart attack, stroke, dementia, and breast cancer [WHI trials]. Bio-identical hormones [chemically endogenous hormones] have gained popularity and can be mixed according to physician's orders by compounding pharmacists in the United States. However, there is little published information about the use of such hormones. This paper reports a 12 plus months follow up on 189 patients who were administered natural estrogen plus progesterone with or without DHEA or testosterone according to a rationalized protocol described later. Ninety-seven percent of the patients experienced varying degrees of symptom control, whereas three had minimal or questionable benefit. Mental symptoms experienced upon presentation improved in 90% of the patients. Sixty percent of the patients, who had gained weight during menopause, lost an average of 14.8 lbs [SD 11.98 lbs]. Complications described with traditional HRT did not develop in this group of patients. These findings point out a need for larger controlled trials of similar protocols in the management of menopause.
绝经期女性缺乏雌激素、孕激素,并且通常缺乏睾酮和 DHEA。美国的激素替代疗法(HRT)通常由一种或两种药物组成,通常是马雌激素和甲羟孕酮,增加了心脏病发作、中风、痴呆和乳腺癌的风险[WHI 试验]。生物等同激素[化学内源性激素]已经变得流行起来,并且可以根据医生的处方在美国的药剂师那里混合。然而,关于使用此类激素的信息很少。本文报告了对 189 名患者进行了 12 个多月的随访,这些患者根据后来描述的合理化方案接受了天然雌激素加孕激素,或根据情况添加 DHEA 或睾酮。97%的患者经历了不同程度的症状控制,而有 3 名患者的获益极小或有疑问。就诊时出现的精神症状在 90%的患者中得到改善。60%在绝经期体重增加的患者平均减轻了 14.8 磅[标准差 11.98 磅]。在这组患者中未出现传统 HRT 描述的并发症。这些发现表明需要对类似方案的更大规模对照试验来管理绝经期。